Turning Point Brands Reports 22.6% Sales Increase but 75.2% Decline in Net Income for Q2 2026

Turning Point Brands, Inc. reported its financial results for the second quarter of 2026, revealing a consolidated net sales increase of 22.6% to $142.96 million, compared to $116.63 million in the same period last year. The growth was primarily driven by a significant 54.5% increase in the Stoker’s products segment, which generated $107.58 million in sales, while the Zig-Zag products segment saw a decline of 24.8%, bringing in $35.38 million. The company’s gross profit rose 40.6% to $93.70 million, with gross profit margins improving to 65.5% from 57.1% year-over-year, largely due to tariff refunds that reduced cost of sales.

Despite the increase in sales and gross profit, Turning Point Brands experienced a 36.5% decline in operating income, which fell to $16.71 million from $26.33 million in the prior year. This decrease was attributed to a substantial rise in selling, general, and administrative expenses, which surged by 91.1% to $76.99 million. The increase in expenses was driven by higher shipping and selling costs associated with modern oral products, as well as increased salaries and advertising expenses. The company’s net income attributable to Turning Point Brands, Inc. also decreased significantly, falling 75.2% to $3.60 million from $14.48 million in the previous year.

In terms of operational metrics, the company reported a total of 220,000 retail outlets in North America carrying its products, with a notable expansion in its distribution network. The company’s cash position improved, with cash and cash equivalents increasing to $268.31 million as of June 30, 2026, up from $222.76 million at the end of 2025. The company also reported a significant increase in inventory, which rose to $133.43 million from $107.99 million, reflecting its strategy to support future sales growth.

Looking ahead, Turning Point Brands remains focused on expanding its market presence through strategic initiatives, including potential acquisitions and product launches. The company is also closely monitoring regulatory developments that could impact its operations, particularly in the tobacco and nicotine markets. The management expressed optimism about the growth potential in the modern oral products segment, which has been a key driver of revenue growth. However, they acknowledged the challenges posed by increased competition and changing consumer preferences in the tobacco industry.